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Abstract
Background

Pharmacy-led medication reconciliation identifies and corrects medication errors that can
potentially cause moderate to severe harm. This research sought to identify the impact of
pharmacy-led medication reconciliation on patient outcomes and describe the changes in
healthcare workers’ perceptions of the program.

Methods

A pharmacy-led admission medication reconciliation program pilot started in July 2019, and a
discharge medication reconciliation proof of concept was tested in September 2020 at a 432bed hospital. The following periods were compared: August 2018 to February 2019 (pre-program implementation) and August 2019 to February 2020 (post-program implementation).
Endpoints included patient outcomes, workforce productivity and interdisciplinary healthcare
team satisfaction through program surveys. Patient outcomes were assessed with chisquared tests. Survey responses were assessed using the Likert scale. Descriptive statistics
were used for productivity outcomes and the number of discharge medication reconciliations
completed.
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Results

Approximately 18,000 admissions were recorded for each period. The adverse drug event
(ADE) rate decreased 49% (p < 0.001), and the complication rate decreased 29.7% (p =
0.001). During post-pilot implementation, 6,530 medication histories were completed, and
70,050 medications were reviewed. Of medication histories completed, 22.6% of patient allergies/adverse drug reactions were updated, 52.3% of medications were clarified, and 54.7%
of preferred outpatient pharmacies were updated. Pharmacy services completed medication
histories in 38.8% of inpatients. In the proof of concept, 168 discharge medication lists were
drafted. Survey results showed statistically significant improvement in healthcare team
satisfaction.

Conclusion

A pharmacy-led medication reconciliation program involving designated pharmacists and
pharmacy technicians has shown to decrease ADEs and complications while improving interdisciplinary healthcare team satisfaction.
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Background

Medication reconciliation serves as a crucial
component of delivering high-quality patient
care. The Institute for Healthcare Improvement defines it as “the process of creating the
most accurate list possible of all medications a
patient is taking—including drug name, dosage,
frequency, and route—and comparing that list
against the physician’s admission, transfer, and/
or discharge orders, with the goal of providing correct medications to the patient at all
transition points within the hospital”.1 Upon
admission, medication reconciliation involves
verifying a patient’s outpatient medication information and ensuring that appropriate medications are continued during hospitalization.
At the time of discharge, inpatient and home
medication lists are reviewed, and actions are
taken to ensure that appropriate medications
are continued, resumed or discontinued upon
transition to the home or outpatient care setting.
In a traditional medication reconciliation workflow, direct-care nurses and physicians are
responsible for ensuring drug regimen accuracy with minimal pharmacist input. It has been
estimated that 87% of emergency department
medication lists have at least one error when
medication histories are completed by emergency department staff.2 Medication histories
are often incomplete as a possible result of patients lacking an accurate picture of their medication regimen, healthcare providers working
to triage more immediate patient needs,
clinical settings having frequent distractions,
or “illegible medication lists accompanying the
patient”.2 In a statement from the Emergency
Nurses Association, the committee identified
that “the use of pharmacy staff to complete
the Best Possible Medication History (BPMH)
and conduct the reconciliation evaluation saves
time and reduces medication discrepancies”.3
Since medication reconciliation and the early
identification of drug therapy problems play
an integral role in establishing a continuum of
care and safe medication use, their absence or
incompletion can lead to worse than expected
patient outcomes, such as increased inpatient
readmissions, adverse drug events (ADEs),
complications and increased utilization of the
emergency department.4
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Pharmacy-led medication reconciliation alleviates some burden from the emergency department staff while providing a more robust and
comprehensive medication list.3 A study comparing the medication lists gathered by emergency department clinical pharmacists versus
their physician counterparts found that pharmacists completed the medication reconciliation with 100% accuracy, while the physician
group reported an accurate medication history
22% of the time.5 Mekonnen and colleagues
reported a 66% reduction in medication discrepancy errors at both hospital admission and
discharge through pharmacy-led medication
reconciliation.6
Pharmacy-led medication reconciliation helps
identify and correct medication errors that
often carry the potential to cause moderate
to severe patient harm, such as ordering an
antihypertensive medication for a hypotensive
patient or omitting allopurinol on the medication list for a patient with hyperuricemia.7 The
impact of pharmacy-led medication reconciliation is especially valuable for a hospital given
the incentives from various organizations. The
Joint Commission has incorporated medication
reconciliation as a national patient safety goal
since 2005.8 In 2012, the Centers for Medicare
and Medicaid Services (CMS) established the
Hospital Readmission Reduction Program
(HRRP) to reduce financial burden in light of a
study estimating that 30-day readmission rates
for Medicare patients cost the United States
healthcare system an estimated $17 billion in
2004.9
Despite evidence to support pharmacy-led admission medication reconciliation, less is known
about the long-term impact of an operationalized program in providing safe and effective
care, decreasing readmissions and assessing
interdisciplinary healthcare team satisfaction.
The model created in this study seeks to expand pharmacy-led medication reconciliation to
identify drug therapy problems upon admission
and address any lingering medication discrepancies or issues prior to discharge. The purpose
of this research was to identify the impact of
pharmacy-led medication reconciliation on
patient outcomes and describe the change in
perceptions of healthcare workers with pharmacy-led medication reconciliation.
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Methods

A pilot program implementing pharmacy-led
admission medication reconciliation was initiated in July 2019, and a 10 hour per day discharge
medication reconciliation proof of concept was
tested in September 2020 at a 432-bed hospital offering full-service medical and surgical
acute care.

Description of Pharmacy-Led
Admission Medication Reconciliation

In the admission medication history workflow,
(Figure 1) four certified pharmacy technicians
were hired to serve in a medication history technician role, which included gathering
patient information at the bedside and documenting information in the patient medication
history profile. The profile was also updated to
contain supplementary information, including
medication adherence issues, confirmation of
a primary care physician (PCP), the patient’s
preferred community pharmacy, financial
concerns for drug therapy, and any reported
adverse effects or allergies. Medication history
technicians began with an attempt to interview
the patient. If the patient was unable to complete the interview or did not have a complete
understanding of the medication list, the technicians were trained to then contact entities
outside of the hospital and use multiple sources to verify medication histories. Typically, this
process would include clarifying medications
and doses with caregivers, community pharmacies, long-term care facilities, primary care
providers, and specialists.

A medication reconciliation pharmacist was
hired to manage the medication history technicians and to collaborate with providers
to reconcile each home medication list. The
pharmacist evaluated the list presented by the
medication history technician, rectified drug
therapy issues (e.g., duplication, omissions),
proposed guideline-driven therapies and solved
medication adherence barriers. Any admission
drug therapy issues identified by the pharmacy
team were brought in real-time to the emergency department or the admitting physician
to provide robust care for patients. If a medication-related issue required inpatient follow-up,
then this information was documented and
communicated to the inpatient pharmacists
giving care to the patient. If inpatient medication orders were already entered based on
an outdated medication list, the medication
reconciliation pharmacist notified the physician
of any needed changes immediately following
the completion of medication reconciliation activities. This pharmacist workflow process was
first targeted with patients admitted through
the emergency department and then to patients greater than 65 years of age having medical conditions with a high risk of readmission
(conditions highlighted in this study included
acute myocardial infarction (AMI), coronary
artery bypass graft (CABG), chronic obstructive pulmonary disease (COPD), heart failure
(HF), pneumonia, stroke and total hip or knee
arthroplasty (THA/TKA)) to test high-impact
interventions. For scheduled cardiovascular
surgeries, patients were contacted prior to surgery for a home medication list and identifica-
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Figure 1. Pharmacy-led admission medication reconciliation workflow.
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tion of medication-related issues. Additionally,
a real-time clinical pharmacist transition of care
worklist was developed to ensure continuity
with drug therapy issues that could be resolved
before discharge.
To champion the medication reconciliation program, an interdisciplinary hospital governance
committee was established with responsibilities such as distribution of healthcare team
satisfaction surveys, dissemination of hospital-wide communication on the new service
and identification of gaps and barriers with
current workflows.

Pharmacy-Led Admission Medication
Reconciliation Outcomes

Measures for the admission medication reconciliation program included patient outcomes,
the productivity of the workforce and the
satisfaction of the interdisciplinary healthcare
team. (Table 1) The following periods of data
were compared: August 2018 to February 2019
(pre-program implementation) and August
2019 to February 2020 (post-program implementation). De-identified patient outcome
measures were assessed pre- and post-program using an internal data dashboard tool.
Interdisciplinary healthcare team surveys were
conducted pre- and post-program implementation. The survey was designed to gauge confidence in medication history and reconciliation
practices before and after implementation of
the pharmacy-led admission medication reconciliation program. Survey respondents were
instructed to assess their level of agreement
using a Likert scale (strongly disagree, disagree,

undecided, agree, and strongly agree) and were
offered the opportunity to provide free text for
any comments. Survey questions are detailed in
Table 1.

Description of Discharge Medication
Reconciliation Proof of Concept

In September 2020, a 12-day discharge medication reconciliation proof of concept tested the
addition of remote pharmacists to draft the
discharge medication list for provider approval.
(Figure 2) To prepare the draft discharge medication list, pharmacists held or continued home
medications and continued inpatient medications as new pending prescriptions, if appropriate. Using electronic medical record (EMR)
technology, pharmacists also had the ability to
view which medications would be covered by
the patient’s health insurance. This resource
helped ensure accessibility upon discharge.
Providers were contacted for clarifications and
changes to the medication regimen as necessary. The drafted discharge medication reconciliation was then available for provider review
and approval. Once approved, nurses completed the discharge process as normal.

Discharge Medication Reconciliation
Proof of Concept Outcomes

In the discharge medication reconciliation proof
of concept, the number of medication histories
completed and estimated pharmacist time to
draft the discharge medication reconciliation
during the 12-day period were collected to estimate the impact of the program.
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Figure 2. Remote pharmacist involvement in discharge medication reconciliation workflow.
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Table 1. Outcome Measures of Pharmacy-Led Admission Medication Reconciliation
Measure

Definition
Patient Outcome Measures

All-Cause 30-Day Readmissions

All-cause 30-day inpatient readmissions to the hospital, patients with an
in-hospital mortality on their index stay and patients without an enterprise
master patient index (EMPI) number were excluded.

ADE Rate

Hospital-acquired ADEs (ICD-10 diagnosis) per 1,000 inpatients.

Complication Rate

Total number of complications divided by the total number of eligible cases.

Average Length of Stay (days)

Total number of inpatient days divided by the total number of inpatients.

Mortality Rate

Total number of mortalities divided by the total number of eligible cases.

Total Spend per APD

Total spend divided by adjusted patient days.

CMS Readmissions

Readmissions related to CMS patients, patients with an in-hospital mortality
on their index stay and patients without an EMPI number used to track readmission were excluded. The following conditions were individually assessed:
AMI, CABG, COPD, HF, pneumonia, stroke and THA/TKA.

Productivity of Workforce
Medication Histories Completed

Number of medication histories completed by pharmacy services.

Percent of Histories with Allergies and
ADRs Updated

Patients with allergies and ADRs updated divided by the number of medication histories completed.

Percent of Histories with Medications
Clarified

Patients with medications clarified divided by the number of medication
histories completed.

Percent of Histories with Preferred
Pharmacy Updated

Patients with preferred pharmacy updated divided by the number of medication histories completed.

Total Medications Reviewed

Number of medications documented by pharmacy services.

Average Medications Reviewed per History Completed

Number of medications reviewed divided by the number of medication histories completed.

Percent of Medications Clarified

Medications clarified divided by the number of medications reviewed. Clarifying medications include utilizing outpatient hospitals, pharmacies, primary
care providers, and the prescription drug monitoring program (PDMP) to
obtain complete medication lists.

Percent of Medication Histories Completed

Number of patients with at least one medication history completed divided
by the number of inpatients excluding deliveries, neonatal intensive care unit
(NICU) patients, and newborns.

Satisfaction of Interdisciplinary Health Care Team
Healthcare Team Satisfaction Survey

Question 1: “I feel the staff member performing the admission medication
history is knowledgeable about the medication my patients take at home.”
Question 2: “I feel the staff member performing the admission medication
history is accessible if I have a question or concern about the medication
history and reconciliation for my patients.”
Question 3: “I feel the admission medication history and reconciliation process provides reliable information.”
Question 4: “I feel the admission medication history and reconciliation process leads to better medication orders being written.”

Statistical Analysis

Almost all patient outcomes were assessed
with Pearson’s chi-squared tests. Fisher’s exact
tests were used in the readmission data for
CABG and THA/TKA groups. Data were analyzed using the statistical software R.10 Ratios
were then used for the readmissions groups
by taking the percent of readmissions in the
post-program group and dividing it by the per-

cent of readmissions in the pre-program group.
All survey responses were given a number from
1 to 5 based on the previously mentioned Likert
scale (strongly disagree being assigned with 1,
disagree with 2, undecided with 3, agree with 4,
and strongly agree with 5). From there, a mean
score and standard deviation were calculated
for the survey group overall and then for nurs-
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Table 2. Pharmacy-Led Admission Medication Reconciliation Outcome Measure Results
Measure
Percent Change (%)
p-value
ADE Rate

-49.0

Complication Rate

<0.001

-29.3

0.001

Total Spend per APD

-1.2

Not applicable

Average Length of Stay (days)

-1.0

Not applicable

Mortality Rate

-1.0

Not applicable

All-Cause 30-Day Readmissions

1.01

0.618

CMS Readmissions

1.02

0.831

CMS AMI Readmissions

0.69

0.209

CMS Stroke Readmissions

0.83

0.574

CMS HF Readmissions

1.00

0.982

CMS Pneumonia Readmissions

1.01

0.961

CMS CABG Readmissions

1.31

1.000

CMS COPD Readmissions

1.34

0.295

CMS THA/TKA Readmissions

1.38

0.753

ing, pharmacy and physician subgroups. Responses from the aggregate survey group and
each healthcare discipline group were assessed
with two-sample t-tests.
Descriptive statistics were used to report the
productivity outcomes and the number of
discharge medication reconciliations completed
during the 12 day proof of concept.

Results

Pharmacy-Led Admission Medication
Reconciliation Patient Outcome
Measure Results

From August 2018 to February 2019 compared
to August 2019 to February 2020, inpatient
admissions increased 2.6%, with approximately 18,000 admissions in each period. Between
the two study periods, (Table 2) the ADE rate

decreased 49.0% (p < 0.001) and the complication rate decreased by 29.3% (p = 0.001). Little
difference was observed in the average length
of stay, mortality rate, and the total spend per
adjusted patient day (APD). In the CMS readmission data, AMI and stroke readmissions had
the greatest decreases, with ratios of 0.69 (p =
0.209) and 0.83 (p = 0.574), respectively.

Workforce Productivity Assessment
for the Pharmacy-Led Medication
Reconciliation Program

During post-pilot implementation, 6,530 admission medication histories were completed
and 70,050 unique medications were reviewed
by the medication reconciliation team with
coverage between 0700 and 1700. (Table 3)
Of medication histories completed, 22.6% of
patient allergies/adverse drug reactions (ADRs)
were updated, 52.3% of medications were

Table 3. Workforce Productivity Results (August 2019 to February 2020)
Measure
Medication Histories Completed, n

6,530

Histories with Allergies and ADR Updated, %

22.6%

Histories with Medications Clarified, %

52.3%

Histories with Preferred Outpatient Pharmacy Updated, %
Total Medications Reviewed, n
Average Medications Reviewed per Medication History Completed, n
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Result

54.7%
70,050
10.7

Medications Clarified, %

45.1%

Medication Histories Completed, %

38.8%
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clarified with all available sources (e.g., community pharmacies, long-term care facilities) and
54.7% of preferred outpatient pharmacies were
updated. Medication histories were completed by pharmacy services in 38.8% of hospital
inpatients.

Healthcare Professional Satisfaction
Survey of Pharmacy-Led Admission
Medication History and Reconciliation

A total of 94 interdisciplinary healthcare team

surveys were completed before the admission
medication reconciliation pilot began, and 110
were completed after pilot implementation.
(Table 4) A small percentage of questions in
each survey group were left blank. The corresponding calculated percentages account for
this change in the denominator.
In the pre-pilot survey, nurse respondents were
undecided about the knowledge and accessibility of the individual collecting the medication
history (mean scores 3.15 and 2.86, respective-

Table 4. Healthcare Professional Satisfaction Survey of Pharmacy-Led Admission Medication History and Reconciliation
Survey Question

Pre-Pilot Survey

Post-Pilot Survey

p-value

Mean +
Standard
Deviation

Number of
Responses

Mean +
Standard
Deviation

Number of
Responses

Total

2.89 + 1.16

93

4.34 + 0.87

110

<0.001

Nurses

3.15 + 1.04

41

4.35 + 0.88

82

<0.001

Pharmacists

1.93 + 0.59

15

4.60 + 0.63

15

<0.001

Physicians

2.76 + 1.15

29

3.91 + 1.04

11

0.006

Total

2.71 + 1.17

94

4.16 + 1.02

110

<0.001

Nurses

2.86 + 1.07

42

4.06 + 1.06

82

<0.001

Pharmacists

2.20 + 0.86

15

4.93 + 0.26

15

<0.001

2.48 + 1.15

29

3.91 + 1.04

11

0.001

Total

2.72 + 1.26

93

4.48 + 0.77

110

<0.001

Nurses

3.12 + 1.19

41

4.51 + 0.77

82

<0.001

Pharmacists

1.60 + 0.63

15

4.67 + 0.49

15

<0.001

Physicians

2.31 + 1.04

29

4.09 + 1.04

11

<0.001

Total

3.23 + 1.36

94

4.53 + 0.77

108

<0.001

Nurses

3.64 + 1.16

42

4.51 + 0.81

81

<0.001

Pharmacists

1.87 + 0.99

15

4.86 + 0.36

14

<0.001

Physicians

3.00 + 1.34

29

4.36 + 0.81

11

0.003

“I feel the staff member performing the
admission medication history is knowledgeable about the medication my patients take
at home.”

“I feel the staff member performing the
admission medication history is accessible if I have a question or concern about
the medication history and reconciliation
for my patients.”

Physicians
“I feel the admission medication history and reconciliation process provides
reliable information.”

“I feel the admission medication history
and reconciliation process leads to better medication orders being written.”
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ly), and they were also undecided regarding
the quality of medication reconciliation. The
highest mean score (3.64) was attributed to
the quality of the orders being written through
the medication reconciliation process. However, in the post-pilot survey, nurses reported
mostly strong agreement across all categories.
Mean scores ranged between 4.06 and 4.51. The
number of nurse respondents doubled in the
post-pilot survey versus the pre-pilot survey.
Pharmacist respondents in the pre-pilot survey
indicated predominantly uniform disagreement
in all categories, as evidenced by mean scores
below the midpoint of the Likert scale. The
lowest mean score (1.60) was given to the reliability of the information that the medication
history provides while the highest mean score
(2.20) was given to the accessibility of the
individual performing the medication history. A
significant change occurred in the pharmacist
responses toward the medication history and
reconciliation process in the post-pilot survey
with strong agreement reported in all surveyed
categories. Mean scores between 4.60 and 4.93
were observed with the highest score given to
the accessibility of the person collecting the
medication history.
In the pre-pilot survey, physicians largely disagreed or were undecided regarding the quality
of medication history and reconciliation in the
hospital (mean scores between 2.31 and 3.00).
In the post-pilot survey, physician respondents
indicated moderate agreement in the surveyed
categories. Mean scores ranged between 3.91
and 4.36. The highest mean score (4.36) represented confidence in better medication orders
being written as a result of the quality of the
admission medication history and reconciliation
process.
Overall, statistically significant improvements
in the satisfaction of nursing, pharmacy, physicians and the healthcare team as a whole were
observed in the post-pharmacy-led medication
reconciliation pilot survey. The aggregate survey group scored above the 4 point threshold
on the Likert scale for all surveyed questions.
Respondents agreed or strongly agreed with
the quality of care provided because of implementation of the pharmacy-led medication
reconciliation program.
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Discharge Medication Reconciliation
Proof of Concept Results

During the 12-day discharge medication reconciliation proof of concept, 168 draft discharge
medication reconciliations were completed
with remote pharmacist coverage. The average
remote pharmacist time to draft the discharge
medication reconciliation was 20 minutes per
patient.

Discussion

Comparing the study periods of August 2018
to February 2019 and August 2019 to February 2020, the ADE rate and complication rate
decreased significantly after implementation
of the pharmacy-led medication reconciliation pilot. These findings align with current
literature reports of increased accuracy of
medication lists with pharmacy-led medication
reconciliation, which reduces ADEs leading to
diminished opportunities for patient harm.4,7
Trends between CMS readmission groups were
an interesting finding, as only AMI and stroke
groups experienced a decrease in readmissions. The lack of uniform decrease in readmission among all groups could be attributed to
more interventions made with anticoagulant
medications and easier identification of errors
in post-stroke medication lists upon discharge.
Cardiovascular surgery patients became initial
targets for pharmacotherapy interventions
early in the pilot program’s course, so this
group experienced a broader scope of time for
an impact to be made. The interdisciplinary
survey provided insight into the satisfaction
of the interdisciplinary healthcare team with
the pharmacy-led medication reconciliation
pilot program. Nurse, pharmacist and physician
groups all saw a significant increase in mean
survey scores with most of those respondents
agreeing or strongly agreeing with the positive
impact of the program on medication orders
and patient care.
The medication reconciliation team was able
to complete medication histories for 38.8%
of inpatients with one medication reconciliation pharmacist and 4 medication history
technicians. At the start of the program, the
team staffed the highest volume days of the
week for hospital patient admissions Monday
through Friday from 0700 to 2330. Working
hours were subsequently adjusted to 0700 to
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2000 for easier access to community pharmacies for patient medication information. Hours
were also expanded to provide weekend coverage as the team grew over time. Unit-based
pharmacists and an emergency department
pharmacist provided assistance in medication
reconciliation pharmacist duties when the
medication reconciliation pharmacist was not
available. Based on lessons learned from the
pilot, one additional medication reconciliation
pharmacist and three medication history technicians were hired to expand the program’s
reach to a greater percentage of inpatients.
Common themes emerged in the types of interventions performed through the medication
reconciliation program. The pharmacy team
encountered several instances of medications
that did not have a specific hospital formulary
substitution, so they were omitted by the admitting physician while completing admission
medication reconciliation. Prior to program
implementation, these omissions caused critical gaps in patient therapy (especially for oral
chemotherapy agents or human immunodeficiency virus (HIV) medications). During admission medication reconciliation with a pharmacist, issues with non-formulary medications
were solved at the time of admission. If there
was an appropriate substitute, the pharmacist
would communicate with the provider and
initiate a substitution. During inpatient care,
if a substitution was not available, the medication reconciliation pharmacist would ensure
the patient’s own medication hospital policy
and process was initiated. Medication reconciliation pharmacists communicated the omitted
medication with the provider, ensured that a
family member could provide the medication,
loaded the medication into the automated
dispensing cabinet and added the medication
to the electronic medication administration record (eMAR) to bring awareness to the healthcare team.
During admission medication history compilation, medication history technicians were
trained to ask patients about non-oral medication formulations. The team found that
medication patches and pumps often were
omitted from the admission home medication
list prior to pharmacy involvement. The medication reconciliation team often intervened
with inpatient pain management and diabetes

management upon learning of these medications at the time of the admission medication
history. The medication reconciliation pharmacist would immediately contact the inpatient
physician team to make them aware of nonoral drug therapy and thus prevent opportunities for duplication of medication therapy that
could lead to medication overdoses. Additional
intervention opportunities involved discovery of non-adherence due to patient financial
issues. For example, a provider increased the
dose of anti-hypertensive medications based
on doses listed from a previous visit for a
patient with hypertensive urgency. During
medication history and reconciliation, it was
identified that the patient had not taken any
medications for hypertension in several weeks
due to cost issues, which led to their current
admission. Upon learning of patient financial
constraints, the medication reconciliation
pharmacist informed the attending physician
of alternative medication options to improve
outpatient medication adherence. This scenario has been observed with medications for
diabetes, COPD, seizures and diuresis as well.
Commentary on the program from survey
respondents frequently included the time and
effort saved that was re-directed to address
immediate patient care needs in keeping with
similar findings in the literature.2,3 One respondent mentioned that the program “helps
cut time off admissions” and that medication
histories performed by pharmacy staff “are
more accurate than what I can get from the
patients”. Another healthcare team member
mentioned that “this process should be integral to [the] care of all patients. [Its] value is
limitless when it comes to safer patient care”.
A nurse in the emergency department spoke to
the value of the medication history technician
as “one of the biggest safety wins for our hospital! They provide invaluable knowledge and
have caught numerous [errors] that may have
gone undetected or even caused harm”. Finally,
the hospital emergency department medical
director and physician champion for the medication reconciliation program mentioned that
it “has quickly become an invaluable resource
to our emergency department”. He also highlighted that the efficient time frame in which
medications are updated by the program has
resulted in “decreased drug interactions, accurate dosing of medications and [the] avoidance
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of giving medications that patients are no
longer taking.”
A strength of this study was in the survey
design. Providing a brief questionnaire allowed
for wider participation among hospital staff
and enabled the authors to gauge interdisciplinary agreement with medication history
and reconciliation pre- and post-pilot. Results
captured the improvement in interdisciplinary
satisfaction after pharmacy services involvement, indicating the greatest opportunities for
future program impact.
The shortened time periods of the study
presented a limitation. The decision to incorporate post-pilot data through February
2020 was made to isolate the impact of medication reconciliation during normal hospital
processes before the COVID-19 pandemic.
However, during the COVID-19 pandemic, we
have observed positive effects of the program
to decrease ADEs, complications and 30-day
readmissions while noting concurrent hospital initiatives may limit the ability to attribute
study findings solely to the medication reconciliation program.
As pharmacy involvement in medication history and reconciliation continues to expand, further research will be needed to replicate these
results using similar medication reconciliation
models in hospitals of varying size. Additionally, comparisons of data over longer periods of
time may be considered to advance research
in this area. Moving forward, the hospital has
increased its staffing of medication history
technicians and added a second medication
reconciliation pharmacist to achieve a higher
percentage of patient admission medication
histories, and the discharge medication reconciliation workflow has been piloted by two
other hospitals in the health system for further refinement.
The impact of the medication reconciliation
pilot program cannot be understated, as these
results were used to create a comprehensive,
pharmacy-led medication reconciliation program for other hospitals in the health system.
Emergency department staff continue to
rely on the program to establish a foundation
necessary for high-quality patient care. Pharmacists have shifted their focus to the patient
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bedside, enhancing the level of medication
management they provide to patients. The
pharmacy team continues to identify innovative ways to assist patients with their medication regimens. The program has expanded its
role in the hospital’s elective surgery department by calling patients prior to scheduled
surgeries. The medication reconciliation program credits The Joint Commission’s National
Patient Safety Goal in medication safety as a
foundational resource to guide its establishment, growth and success.
The medication reconciliation pharmacists
have enhanced their ability to address medication adherence concerns through student
pharmacists and pharmacy residents. The
medication reconciliation pharmacist supervisor has spoken to the value of the program,
saying “Being a medication reconciliation pharmacist allows me the opportunity to optimize
and individualize medication therapy regimens
for each and every patient that comes into our
hospital. No two patients are the same, and it
is imperative we create a medication regimen
from admission that is the most likely to lead
to successful transitions of care on discharge.”
Overall, the program has ingrained medication
reconciliation into the culture of the pharmacy
department’s operations, and it has continued to empower pharmacy staff to highlight
the value of their work to the interdisciplinary
healthcare team. As the hospital director of
pharmacy has stated of the program, “We are
changing the paradigm of inpatient care”.

Conclusion

Implementation of a pharmacy-led medication
reconciliation program involving designated
pharmacist and medication history technician roles decreased adverse drug events and
complications significantly. Significant positive change was observed in interdisciplinary
healthcare team satisfaction after the admission pharmacy-led medication reconciliation
pilot implementation. The interdisciplinary
healthcare team has credited the program with
reducing medication errors, creating a comprehensive and accurate medication list and
conserving provider and nursing time.
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